★ 192 · Updated 2026-10-06
Analyzes regenerative medicine products across cell therapy, gene therapy, scaffolds, potency assurance, CMC, and regulatory pathways.
Browse skills that use this input.
★ 192 · Updated 2026-10-06
Analyzes regenerative medicine products across cell therapy, gene therapy, scaffolds, potency assurance, CMC, and regulatory pathways.
★ 0 · Updated 2026-10-04
Reviews a finished design-system document or amend delta against usability, consistency, coverage, accessibility, and governance criteria, then emits an approve or revise verdict.